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Instead of considering aging in terms of discrete hallmarks, we suggest that it operates in four layers, each at
a different biological scale. Malfunctions within each layer—and connections between them—produce the
aged phenotype and its associated susceptibility to disease.The defining feature of the last period of life, aging is character-
ized by the progressive loss of physiological integrity, leading
to impaired function and increased vulnerability to death. A full
understanding of the aging as a process, however, is greatly
impeded by its complexity. Geroscience studies the genetic
and environmental contributions to diseases associated with
aging; the goal is a mechanistic understanding of these rela-
tionships at the molecular, network, and systems levels. A
large number of aging mechanisms have been proposed,
including maladaptive chronic inflammation, oxidative stress,
cellular senescence, and genome instability (Balaban et al.,
2005; Campisi, 2013; Franceschi et al., 2007; Vijg and Suh,
2013). Many studies emphasize these different manifestations
of aging as discrete processes and largely neglect their inherent
connections.
Here, instead of considering aging as a set of isolated pro-
cesses, we discuss aging in terms of ‘‘four layers,’’ each at a
different biological scale. From an overall phenotype to a molec-
ular mechanism, the four layers of aging are as follows: the
organism’s decline in physical function and increased suscep-
tibility to diseases (layer 1); systemic immune, metabolic, and
endocrine dysfunction (layer 2); cellular malfunction (layer 3);
and failure of biomolecule maintenance (layer 4). In this context,
we briefly discuss the problems of disentangling cause from
consequence in aging, speak to the question of aging as a devel-
opmental program, and evaluate strategies for treating age-
related diseases.
FOUR LAYERS OF AGING
Layer 1: Decline in Physical Function and Increased
Susceptibility to Diseases
Themost obvious layer of aging, layer 1, is the organism’s overall
physical deterioration, functional decline, and increased suscep-
tibility to age-related diseases (Figure 1A).
Age-associated organismal degeneration is concomitant
with tissue-level changes in cell number and composition.
For example, the wasting of tissues during age is ubiquitous
and frequently attributed to stem cell depletion. By contrast,
cancer presents as a unique class of age-related diseases,
which are characterized by uncontrolled cellular proliferation
rather than cellular loss. While age-related diseases appear
to be independent and diverse from the perspective of layer
1, their inherent connections are revealed in layers two
through four.180 Cell Systems 1, September 23, 2015 ª2015 Elsevier Inc.Layer 2: Systemic Immune, Metabolic and Endocrine
Dysfunction
Layer 2 comprises the systems that regulate the body’s physi-
ology. It links cellular level changes, like the production of
cytokines, to organism-level phenotypes, like cardiovascular
diseases and cancers. Here, we focus on chronic inflammation,
metabolic deregulation resulting from aberrant nutrient-sensing,
and endocrine dysfunction as examples of systems found in this
layer (Figure 1B).
Under normal, adaptive physiological conditions, inflammation
helps clear pathogens and heals wounded tissues. However, the
chronic low-grade inflammation that develops during aging con-
tributes to the onset and development of age-related diseases.
This relationshipwas established by studies that inhibited inflam-
mation and observed that this intervention protects against age-
related diseases. For example, genetic inhibition of the inflam-
matory nuclear factor (NF)-kB pathway attenuates amyotrophy,
insulin resistance, and neurodegeneration and prolongs the life-
span of mice (Cai et al., 2004; Cai et al., 2005; Li et al., 2012;
Zhang et al., 2013). Likewise, ablation of theNlrp3 inflammasome
protects mice from age-related astrogliosis, glucose intolerance,
bone loss, and thymic involution (Youm et al., 2013). Recently,
type I interferon (IFN-I) signaling was reported to increase in
the choroid plexus upon aging, and blocking IFN-I signaling in
the aged brain alleviates cognitive decline (Baruch et al., 2014).
Due to the intimate relationship between inflammation and aging,
the neologism ‘‘inflammaging’’ is frequently used to describe
the low-grade pro-inflammatory patient status seen in old age.
Given these studies and similar ones, it can be inferred that
the body’s own inflammatory response either causes age-
related diseases directly or makes them more likely in older
individuals.
In addition to chronic inflammation, another age-associated
systemic change is metabolic dysfunction. To date, it has been
inferred that four conserved nutrient-sensing pathways are de-
regulated in old individuals; correcting this disregulation with
diet or caloric restriction promotes longevity and health. The
four pathways are: (1) Insulin/insulin-like growth factor (IGF)-1
signaling (IIS). The best-characterized aging pathway is the IIS
pathway (Kenyon et al., 1993); downregulation of the IIS pro-
longs the lifespan in diverse species. (2) Sirtuins. Sirtuins are
a family of NAD+ dependent protein deacylases and ADP ribosyl-
transferases. Consistentwith the pro-survival effects of sirtuins in
yeast, worms, and flies, Sirt6 transgenic mice (Kanfi et al., 2012)
and brain-specific Sirt1-overexpressing mice (Satoh et al., 2013)
Figure 1. The Four Layers of Aging
(A) The most superficial layer of aging is reflected by a large number of seemingly independent age-related diseases, while leaving the inherent connections
unrevealed.
(B) The 2nd layer of aging ismainly embodied by three interlinked pathophysiological changes: chronic inflammation, nutrient-sensing deregulation and endocrine
dysfunction. During aging, there is a systemic increase in proinflammatory cytokines, a relative energy excess, inappropriate activation of insulin/insulin-like
growth factor (IGF) signaling and deregulation of protective serum factors (e.g., myokines). Consequently, an inflammatory-metabolic molecular network is
activated, which lays the foundation for age-related diseases. Lifestyle factors, including dietary/caloric restriction and regular physical activity, have extensive
effects on the second layer of aging to promote health and longevity. GH, growth hormone; NF-kB, nuclear factor-kB; AMPK, adenosine monophosphate-
activated protein kinase; mTOR, mechanistic target of rapamycin; FOXO, forkhead box O.
(C) At the cellular level, aging is caused or accompanied by a series of cellular malfunctions. In general, a healthy cell has a regular cell cycle, efficient oxidation
and phosphorylation (OXPHOS) in mitochondria, organized biosynthesis (in the ER) and scavenging (e.g., autophagy) systems, and a clean secretome that is well
matched to its functionality. By contrast, an aged cell tends to undergo cell-cycle arrest (cellular senescence), mitochondrial dysfunction, biosynthesis in-
efficiency, ER stress and toxic protein accumulation, and the appearance of the senescence-associated secretory phenotype (SASP) is observed. ROS, reactive
oxygen species.
(D) Biomacromolecules, including nucleic acids and proteins, continuously suffer from exogenous and endogenous insults. When these insults overbalance the
inherent protective mechanisms (e.g., DNA repair, autophagy, and antioxidation), the normal structures and functions of biomolecules are affected (directly and
indirectly). DNA damage, telomere attrition, epigenetic alterations, a loss of proteostasis and possibly RNA damage, which jointly constitute the innermost layer of
aging, are observed. UV, ultraviolet.
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(AMPK). Activation of AMPK prolongs the lifespan of worms
and flies (Apfeld et al., 2004; Stenesen et al., 2013; Ulgherait
et al., 2014). (4) Mechanistic target of rapamycin (mTOR). The
mTOR pathway is activated by nutrients (e.g., amino acids) or
hormonal cues (e.g., insulin and growth factors). The downregu-
lation of mTOR universally extends the lifespan of model organ-
isms, includingmammals (Harrison et al., 2009). These examples
highlight the intimate connection between metabolism, intracel-
lular signal transduction, and the lifespan of the organism. They
demonstrate that metabolic deregulation and aberrant nutrient-
sensing are a prominent feature of aging.As discussed earlier, the ablation of key intermediates in the
IIS pathway extends the lifespan (Kenyon et al., 1993). This result
led researchers to infer that the sustained elevation of the IIS
axis ages individuals prematurely. However, other hormones
have the opposite effect. Oxytocin, a neurohypophysial hor-
mone, has also been found to decrease with age and is required
for muscle maintenance and regeneration (Elabd et al., 2014).
Similarly, muscle-derived cytokines (myokines), many of which
can be induced by physical activity, also protect against aging.
For example, a recent report showed that muscle-derived
Myoglianin extends the lifespan of Drosophila (Demontis et al.,
2014) and growth differentiation factor (GDF) 11, a mammalianCell Systems 1, September 23, 2015 ª2015 Elsevier Inc. 181
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seen in parabiosis experiments (Katsimpardi et al., 2014; Lof-
fredo et al., 2013; Sinha et al., 2014; Villeda et al., 2014). (Impor-
tantly, although young blood was observed to reverse multiple
age-related pathologies, GDF11’s ability to promote skeletal
muscle regeneration has been recently called into question
[Egerman et al., 2015].) As with nutrient-sensing deregulation,
it can be inferred that one cause or consequence of aging is a
tuning of these pathways away from their protective functions
and toward pathological ones.
Importantly, within the second layer of aging, inflammation
and metabolic dysfunction each compound the other’s effects
because these systems are interconnected. Through the IKK/
NF-kB and JNK/AP1 pathways, chronic inflammation represses
insulin sensitivity and reduces the utilization of nutrients by
peripheral tissues (Han et al., 2013; Wang et al., 2014). Con-
sequently, excess nutrients accumulate and contribute to low-
grade inflammation (Shi et al., 2006), thereby laying the founda-
tion for the development of age-related diseases (Figure 1B).
Layer 3: Cellular Malfunction
Cell-autonomous programs can affect an organism’s longevity;
these programs malfunction more frequently as organisms and
cells age. Layer 3 is comprised of such cellular programs. In
some cases, they have both pro- and anti-aging effects; which
effect dominates depends on cellular context. These ideas are
discussed below as we focus on four examples that illustrate
cellular malfunction during aging (Figure 1C).
First, the number of senescent cells in the body increases with
an organism’s age. Cellular senescence is the stable, likely regu-
lated, arrest of cell proliferation. As with many age-related phe-
notypes, cellular senescence is not only simply pathological
but also a programmedmechanism with important physiological
functions. Recent studies have reported that senescent cells are
widespread throughout the developing embryo, and the loss of
senescence results in detectable developmental abnormalities
(Mun˜oz-Espı´n et al., 2013; Storer et al., 2013). After develop-
ment, senescent cells play important protective roles. They
secrete a large number of cytokines, chemokines, growth fac-
tors, and proteases, which are collectively referred to as the
‘‘senescence-associated secretory phenotype’’ (SASP) (Coppe´
et al., 2008). Ideally, SASP recruits immune cells to clear senes-
cent cells and repair damaged tissues. However, chronic, unre-
solved inflammation induced by the SASP may impair normal
function and lead to the development of cancers (Yoshimoto
et al., 2013), as discussed above, in layer 2.
Second, a progressive, age-related decline in the mitochon-
drial respiratory chain leads to electron leakage and increased
production of reactive oxygen species (ROS) within cells. It
is challenging to connect this cellular-level dysfunction to
organismal aging, and although it is well-established that oxida-
tive stress contributes to diverse, age-related diseases (Abe and
Berk, 1998; Rosen et al., 1993), the classical free radical theory of
aging is oversimplified. For example, intrinsic ROS are a conse-
quence of normal mitochondrial function or low levels of oxida-
tive stress. Recent studies suggest that, perhaps counter-intui-
tively, intrinsic ROS are important for disease prevention or
even lifespan extension (Sayin et al., 2014; Weimer et al., 2014;
Yee et al., 2014). In addition to the protective ‘‘ROS defense,’’182 Cell Systems 1, September 23, 2015 ª2015 Elsevier Inc.the mitochondrial unfolded protein response (UPRmt) is a con-
served mechanism that promotes longevity (Houtkooper et al.,
2013). These examples suggest that the cell’s response to mild
mitochondrial stress can restore homeostasis, while only severe
mitochondrial dysfunction causes age-associated damage that
affects the lifespan of the organism.
Third, upon impaired protein folding or metabolic deregulation
(e.g., energy or nutrient depletion, changes in intracellular cal-
cium concentration, redox imbalance, etc.), the ER’s unfolded
protein response (UPRer) is activated in healthy cells. However,
while these problems becomemore frequent with age, the ability
of the UPRer to induce molecular chaperone functions declines
as organism ages. Accordingly, correcting this defect genetically
has positive effects. In S. cerevisiae, the induction of the UPRer is
required for certain forms of the lifespan extension (Labunskyy
et al., 2014). InC. elegans, forced expression of xbp-1 s, a UPRer
activator, reverses age-onset loss of ER proteostasis and over-
expression of xbp-1 s increases the worm lifespan (Taylor and
Dillin, 2013). By enhancing ER-associated protein degradation
in individual cells, hexosamine pathway activation extends the
lifespan of worms (Denzel et al., 2014). These findings imply
that moderate ER stress response helps maintain cellular ho-
meostasis, which tends to increase an organism’s lifespan.
Notably, high levels of sustained ER stress, however, causes
adverse inflammation and apoptosis (Lin et al., 2007; Zhang
et al., 2006).
Fourth, an age-associated decline in the cell’s ability to
degrade specific proteins, specifically defects in the auto-
phagy-lysosome and ubiquitin-proteasome systems, contrib-
utes to the pathologies seen in multiple age-related diseases
(Lipinski et al., 2010; Tomaru et al., 2012). Accordingly, gain-
of-function studies show a protective effect: activation of these
cellular programs increases an organism’s health and longevity.
Overexpression of autophagy-specific gene 8a (Atg8a) prevents
age-dependent damage accumulation in neurons and enhances
longevity inDrosophila (Simonsen et al., 2008). Likewise, overex-
pression of autophagy related 5 (Atg5) improves insulin sensi-
tivity, motor function, and extends the lifespan of mice (Pyo
et al., 2013). Overexpressing LAMP2A, a chaperone-mediated
autophagy receptor, also delays the aging-associated decline
in hepatic function in mice (Zhang and Cuervo, 2008). Similarly,
increasing the activity of the ubiquitin-proteasome system pro-
tects cells from proteotoxic stress and extends the lifespan of
yeast and worms (Chondrogianni et al., 2015; Kruegel et al.,
2011; Liu et al., 2011).
Layer 4: Failure of Biomolecule Maintenance
Macromolecules malfunction in aged individuals because the
damage caused by environmental insults and failures of cellular
homeostasis is not fully repaired. On the molecular level, there-
fore, aging presents as a failure of biomolecule maintenance
(Figure 1D).
On the DNA level, damage accumulates during aging (Maslov
et al., 2013) and inserts mutations into the genome. Chromo-
some structure also changes as telomeres undergo progressive,
age-related attrition in most somatic cells. Through genome-
wide meta-analysis, loci affecting telomere length have been
associated with age-related diseases, including cancers and
coronary artery disease (Codd et al., 2013). Mutation and altered
Figure 2. Interlayer Connections within the Aging Cascade
The phenotypes associated with aging can be categorized into four layers, each at a different biological scale. While the inner layers lay the foundation for the
outer layers, the outer layers also effect the inner layers. Examples of these connections are indicated with the numbered arrows; each arrow is defined as follows.
1. p53/p21 activation. 2. Damaged cell clearance. 3. mtDNA-electron transport chain (ETC) problem. 4. Oxidative stress. 5. UPRmt. 6. OXPHOS inefficiency. 7.
Oxidative stress. 8. Protein folding stress. 9. UPRer. 10. Cytochrome C release. 11. CHOP, JNK activation. 12. Calcium flux. 13. SASP. 14. ROS overproduction.
15. Cross talk with NF-kB, AP-1 pathways. 16. Endocrine tissue dysfunction. 17. Respiratory decline. 18. Sirt1, AMPK inhibition. 19. Insulin resistance. 20. Lipid
overload. 21. NF-kB, AP-1 activation; adipokine release. 22. Insulin resistance. 23. Immune cell infiltration. 24. Angiogenesis. 25. Insulin resistance. 26. As-
trogliosis; the activation of interferon, NF-kB, inflammasome pathways. 27. Immunosenescence. 28. Sirt1, AMPK inhibition. 29. mTOR activation; Warburg effect.
30. Nutrient overload. 31. Cholesterol turnover; NAD+ decline. 32. mTOR activation; AMPK inhibition.
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aged cells fail to maintain normally silent heterochromatin and
histone occupancy (De Cecco et al., 2013a; O’Sullivan et al.,
2010; Zhang et al., 2015); this circumstance allows transposable
elements, which can cause genome instability, to bemore active
(De Cecco et al., 2013b; VanMeter et al., 2014). Epigenetic mod-
ifications, including DNA methylation, histone methylation, and
histone acetylation, also undergo extensive changes during ag-
ing (Hannum et al., 2013; Horvath, 2013; O’Sullivan et al., 2010),
and alterations of the nuclear lamina, which participates in
chromatin organization, are seen with age (Chen et al., 2014).
In replicating cells, chromosomal segregation errors also likely
contribute to aging: increased expression of the spindle-assem-
bly checkpoint component, BubR1, extends the healthy lifespan
(Baker et al., 2013).
At the protein level, chaperone function and regulated proteol-
ysis decline with aging (discussed in layer 3). A recent quantita-
tive proteomics study of worms confirmed that the proteome
undergoes widespread remodeling and aggregation during ag-ing (Walther et al., 2015). This likely reflects that problems within
layer 3 are compounded with mutation and/or mis-translation er-
rors within proteins themselves (layer 4).
Conceptual Implications of the Four Layers of Aging
Cause versus Consequence
Separating the aging process into layers illustrates the problem
of disentangling cause and consequence, a fundamental chal-
lenge to understanding aging. Each layer affects the others, so
isolating the ‘‘root cause’’ of aging post hoc is difficult if not
impossible. For example, DNA damage (layer 4) activates the
complex DNA repair response to maintain genome integrity. If
the damage is not repaired in time or effectively enough, cellular
senescence or apoptosis (layer 3) will be induced (Wang et al.,
2009). Senescent and damaged cells secrete cytokines to
communicate with the surrounding tissue (Rodier et al., 2009),
which can produce chronic, organism-wide inflammation (layer
2), especially if the organism is already prone. This, in turn has
the side-effect of producingmore DNA-damaging ROS. All theseCell Systems 1, September 23, 2015 ª2015 Elsevier Inc. 183
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ganism-level decline (layer 1). Notably, while this example begins
with layer 4 for illustrative purposes, the initial damage may
occur at any level and percolate up or down the layers of aging
(Figure 2).
Aging as a Developmental Program
The inevitability of the aging process raises the hypothesis that
aging is programmed. However, we argue that when analyzed
from the four layer perspective, this ‘‘aging program’’ is relatively
unlikely in most higher organisms for three reasons. First, the bio-
molecular damage (layer 4) caused by exogenous insults is an
important driving force of aging. Hence, one primary impetus to
age is beyond genetic control. Second, layers 2 and 3 contain
many ‘‘double-edged’’ programs. For example, inflammation is
a vital, protective process: it clears pathogens and heals wounds
in normal physiological contexts. Inflammation also contributes
to aging using similar, if not identical, molecular-level processes.
From the perspective of evolution, it is trivial to see the selective
benefit of healing, especially during early life and reproduction,
but the benefits of aging are unclear. Thus, the ‘‘programmed’’
cellular malfunction seen in aging is likely a by-product of mech-
anisms evolved to protect individuals against illnesses rather than
promote aging. Finally, the overall vulnerability and susceptibility
to diseases described in layer 1 directly impair Darwinian fitness
and threaten the survival of the organism. For these reasons, ag-
ing appears to be a byproduct of living rather than a purpose.
Strategies to Prevent Aging and Age-Related Disease
The four layers suggest that anti-aging strategies will face signif-
icant challenges. The disadvantages of targeting systemic im-
mune, metabolic, and endocrine dysfunction (layer 2) or cellular
malfunction (layer 3) in treating diseases should be noted. Sup-
pressing these processes may treat one disease at the expense
of normal functions. For example, targeting senescence may
alleviate tissue wasting but most likely will also cause dysplasia
and increase cancer risk. Similarly, the attenuation of inflamma-
tion holds great promise for the prevention of age-related dis-
eases but will inevitably impair immune functions. In addition,
the inhibition of the IIS system prolongs the lifespan but impedes
growth and fecundity at the same time. Fortunately, although tar-
geting the IIS pathway causes adverse effects on development
and reproduction early in life, targeting the IIS pathway later in
life may prevent diseases and produce few side effects (Dillin
et al., 2002). Hence, timing is an important factor that should
be taken into account when targeting layers 2 and 3.
Although we ultimately die in a stressful state, it has been pro-
posed that excessive stress (ROS, for instance) may not always
be the factor that initiates complex diseases, but rather a lack of
proper stress (Watson, 2014). In a sense, dietary restriction or
caloric restriction (DR/CR) serves as a low dose of stress that
triggers a series of protective mechanisms found in layers 2
and 3 to promote the maintenance of the soma. However, given
that these responses are ‘‘double-edged’’ as discussed above,
excessively stringent DR/CR may impair development, growth,
reproduction, and other physiological functions that are impor-
tant for early life (Dirks and Leeuwenburgh, 2006). Therefore,
the intensity and the timing of the stress are both critical for a
stress to promote health and longevity.184 Cell Systems 1, September 23, 2015 ª2015 Elsevier Inc.The core layer of aging (layer 4) consists of damage and alter-
ations to biomolecules. Although damage is essentially unavoid-
able throughout one’s lifetime, it could be promising to exploit
intrinsic adaptive responsive mechanisms, such as DNA dam-
age repair, the UPRs and autophagy, to guard the normal func-
tions of biomolecules, to impede the aging cascade. Notwith-
standing the extreme difficulty of this approach, strategies
aimed at the innermost layer of aging may be ideal and perma-
nent cures for aging and diseases.
Concluding Remarks
Recent studies havemade significant contributions to our under-
standing of aging as a process, and new strategies to prevent
aging are continuously proposed. However, from the perspec-
tive of the four layers, we argue that these interventions will
only delay aging for the foreseeable future. We suggest that
age-delaying therapies that effectively utilize the body’s inherent
adaptive responsive mechanisms will have minimal side effects
when they are delivered at the appropriate intensity and time.
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